UK - ISIS Equity reaps 4x money on ScriptSwitch sale
ISIS Equity Partners has wholly exited its investment in drug comparison software company ScriptSwitch via a trade sale to US-based healthcare operator UnitedHealth in a deal that values the business at ТЃ50m, generating a return of four times money.
Coventry-based ScriptSwitch was founded by two students and a pharmacist at the University of Warwick in 2001. The company supplies more than six out of 10 of the UK's primary care trusts, which use its software to provide doctors with information about cheaper generic drug alternatives, as well as data on patient safety and dosage levels. The business generates revenues of about £10m and employs 45 people.
ISIS backed the £9.9m buyout of ScriptSwitch in May 2007. The private equity firm invested £4.6m of equity as part of the replacement capital transaction, which represented a partial exit for previous backer Midven and enabled management to realise some value while also rolling over into the newco. Together, ISIS and Midven owned a substantial minority interest in ScriptSwitch, with management holding the balance.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








